Yee Ming Li, Wong Rosemary, Datta Mineesh, Fazlo Timothy Nicholas, Ebrahim Mina Mohammad, Mcnamara Elissa Claire, De Jong Gerard, Gilfillan Christopher
Department of Endocrinology, Eastern Health, Victoria, Australia
Eastern Health Clinical School, Monash University, Victoria, Australia
Endocrinol Diabetes Metab Case Rep. 2018 Sep 25;2018:18-0091. doi: 10.1530/EDM-18-0091.
Mitochondrial diseases are rare, heterogeneous conditions affecting organs dependent on high aerobic metabolism. Presenting symptoms and signs vary depending on the mutation and mutant protein load. Diabetes mellitus is the most common endocrinopathy, and recognition of these patients is important due to its impact on management and screening of family members. In particular, glycemic management differs in these patients: the use of metformin is avoided because of the risk of lactic acidosis. We describe a patient who presented with gradual weight loss and an acute presentation of hyperglycemia complicated by the superior mesenteric artery syndrome. His maternal history of diabetes and deafness and a personal history of hearing impairment led to the diagnosis of a mitochondrial disorder. Learning points: •• The constellation of diabetes, multi-organ involvement and maternal inheritance should prompt consideration of a mitochondrial disorder. •• Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS) and maternally inherited diabetes and deafness (MIDD) are the most common mitochondrial diabetes disorders caused by a mutation in m.3243A>G in 80% of cases. •• Metformin should be avoided due to the risk of lactic acidosis. •• There is more rapid progression to insulin therapy and higher prevalence of diabetic complications compared to type 2 diabetes. •• Diagnosis of a mitochondrial disorder leads to family screening, education and surveillance for future complications. •• Superior mesenteric artery syndrome, an uncommon but important cause of intestinal pseudo-obstruction in cases of significant weight loss, has been reported in MELAS patients.
线粒体疾病是罕见的、异质性疾病,会影响依赖高有氧代谢的器官。其呈现出的症状和体征因突变及突变蛋白负荷的不同而有所差异。糖尿病是最常见的内分泌病,鉴于其对患者管理及家庭成员筛查的影响,识别这类患者很重要。特别是,这些患者的血糖管理有所不同:由于存在乳酸酸中毒风险,应避免使用二甲双胍。我们描述了一名患者,该患者逐渐体重减轻,并急性出现高血糖,并发肠系膜上动脉综合征。其母亲有糖尿病和耳聋病史,他本人有听力障碍病史,由此诊断为线粒体疾病。学习要点:••糖尿病、多器官受累及母系遗传的组合应促使考虑线粒体疾病。••线粒体脑肌病伴乳酸酸中毒及卒中样发作(MELAS)和母系遗传的糖尿病和耳聋(MIDD)是最常见的线粒体糖尿病疾病,80%的病例由m.3243A>G突变引起。••由于存在乳酸酸中毒风险,应避免使用二甲双胍。••与2型糖尿病相比,这类患者胰岛素治疗进展更快,糖尿病并发症患病率更高。••线粒体疾病的诊断会促使对家族进行筛查、教育及对未来并发症进行监测。••肠系膜上动脉综合征是体重显著减轻病例中肠道假性梗阻的一个不常见但重要的原因,MELAS患者中曾有相关报道。